Overview

Retrospective Evaluation of the Radiographic Efficacy of Conventional and Biologic Treatment

Status:
Completed
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This study involves review and analysis of disease activity in patients with rheumatoid arthritis who where treated with either conventional DMARDs (Disease Modifying Antirheumatic Drugs) or Biologics and have two existing, consecutive radiographs (x-ray images) of hand and feet taken as part of routine treatment monitoring within a time interval of 12 to 36 months.
Details
Lead Sponsor:
Pfizer